• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >Uneventful Pregnancy and Delivery after Thrombolysis Plus Thrombectomy for Acute Ischemic Stroke: Case Study and Literature Review
【24h】

Uneventful Pregnancy and Delivery after Thrombolysis Plus Thrombectomy for Acute Ischemic Stroke: Case Study and Literature Review

机译：溶栓和血栓切除术治疗急性缺血性卒中的孕术和血栓切除术后不满 - 案例研究和文献综述

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BackgroundIntravenous thrombolysis with recombinant tissue plasminogen activator and endovascular mechanical thrombectomy are known to be the most effective treatments in the acute phase of ischemic stroke. However, the safety of intravenous systemic thrombolysis with recombinant tissue plasminogen and endovascular mechanical thrombectomy during pregnancy is not well-confirmed. We describe a case of an uneventful pregnancy and delivery after thrombolysis plus endovascular mechanical thrombectomy for acute ischemic stroke. Materials and MethodsThe patient's medical records were reviewed retrospectively. A comprehensive systemic literature search of the PubMed database was conducted. Case PresentationA 36-year-old woman at 21 weeks gestation presented with a sudden headache, dysarthria, and right hemiparesis. Magnetic resonance angiography revealed occlusion of the left internal carotid artery. Recombinant tissue plasminogen activator was administered intravenously 193 minutes after symptom onset, and endovascular mechanical thrombectomy was started immediately. Recanalization of her left internal carotid artery was achieved. The patient continued to experience mild hemiparesis after the initial treatment and started rehabilitation. The fetus remained in satisfactory condition during the pregnancy and was delivered at 38 weeks without obvious maternal or neonatal complications. No apparent abnormality has been observed in the newborn in the first year of life. ConclusionsIntravenous recombinant tissue plasminogen and endovascular mechanical thrombectomy could be considered as treatment for acute ischemic stroke during pregnancy unless high risks of hemorrhage or preterm labor are expected.
机译：HakightRavenous溶栓与重组组织纤溶酶原激活物和血管内机械血栓切除术，是缺血性卒中急性期的最有效治疗方法。然而，妊娠期间与重组组织纤溶酶原和血管内机械血栓切除术的静脉内全身溶栓的安全性并未得到详细知识。我们描述了一种妊娠期妊娠和溶栓治疗加血管内机械血栓切除术治疗急性缺血性卒中的情况。材料和方法患者的病历是回顾性的。进行了综合的全面的系统文献搜索了PubMed数据库。案例陈述36岁女性在21周的妊娠突然头痛，讨厌和右血管术后呈现。磁共振血管造影显示左内部颈动脉的闭塞。在症状发作后193分钟静脉内施用重组组织纤溶酶原激活剂，立即开始血管内机械血栓切除术。达到了她左内部颈动脉的重新化。初始治疗后，患者继续在初始治疗后体验轻度血清，并开始康复。胎儿在​​怀孕期间令人满意的病情，并在38周内递送，而没有明显的孕产妇或新生儿并发症。在生命的第一年在新生儿中没有观察到任何明显的异常。结论intslavenous重组组织纤溶酶原和血管内机械血栓切除术可以被认为是妊娠期间急性缺血性卒中的治疗，除非预期出血或早产的高风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号